Elena Zafarana
Prato, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Journal: The Lancet. Oncology
Published: November 07, 2022
Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: February 08, 2022
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: August 04, 2020
EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer.
Journal: Breast cancer research : BCR
Published: February 20, 2020
Toward a genome-based treatment landscape for renal cell carcinoma.
Journal: Critical reviews in oncology/hematology
Published: January 18, 2019
Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program.
Journal: Future oncology (London, England)
Published: May 19, 2018
Screening for Frailty in Older Patients With Early-Stage Solid Tumors: A Prospective Longitudinal Evaluation of Three Different Geriatric Tools.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: June 20, 2016
Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13).
Journal: Journal of geriatric oncology
Published: August 30, 2014
Breast cancer in the elderly: which lessons have we learned?
Journal: Future oncology (London, England)
Published: December 04, 2013
The best treatment for older patients with breast cancer.
Journal: EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]
Published: September 01, 2013
Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients.
Journal: Breast (Edinburgh, Scotland)
Published: November 14, 2012
Last Updated: 09/26/2026